首页 > 最新文献

Catheterization and Cardiovascular Interventions最新文献

英文 中文
“Letter to the Editor: Paclitaxel-Coated Balloons for Femoropopliteal Artery Disease Treatment in French Patients: A Longitudinal Observational Study” “致编辑的信:紫杉醇包覆球囊治疗法国患者股腘动脉疾病:一项纵向观察研究”。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-04 DOI: 10.1002/ccd.70314
Syed Ali Raza Zaidi, Taha Yahya, Suleman Arshad, Meer Hassan Khalid
{"title":"“Letter to the Editor: Paclitaxel-Coated Balloons for Femoropopliteal Artery Disease Treatment in French Patients: A Longitudinal Observational Study”","authors":"Syed Ali Raza Zaidi, Taha Yahya, Suleman Arshad, Meer Hassan Khalid","doi":"10.1002/ccd.70314","DOIUrl":"10.1002/ccd.70314","url":null,"abstract":"","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"134-135"},"PeriodicalIF":1.9,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145447050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship of Hemodynamic Improvement and Quality of Life Outcomes After Transcatheter Aortic Valve Replacement 经导管主动脉瓣置换术后血流动力学改善与生活质量的关系。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-03 DOI: 10.1002/ccd.70281
Hamza Lodhi, Houman Khalili, Arthur Pavlovsky, Guilherme Attizzani, Sameer Saleem, Sajjad Haider, Mohammad Abdul-Waheed, Muhammad Akbar, Mohammed Kazimuddin, Amr E. Abbas

Background

Transcatheter aortic valve replacement (TAVR) is a rapidly expanding option for patients with severe aortic stenosis. TAVR has been shown to improve both survival and quality of life. However, the relationship between post-TAVR echocardiographic gradient and quality of life has not been well studied or compared in self-expanding (SEVs) and balloon expandable (BEVs) valves.

Aims

To explore correspondence of post-TAVR echocardiographic gradients and quality of life outcomes.

Methods

In a multicenter retrospective registry of patients undergoing TAVR the relationship between discharge mean gradient (MG) on transthoracic echocardiography (TTE) and quality-of-life scores using Kansas City Cardiomyopathy Questionnaire (KCCQ) was examined at 1 month and 1 year.

Results

During the study period, complete data for 1 month KCCQ and discharge MG data was available in 1093 patients from two high volume institutions. These included 410 (37%) SEVs and 683 (63%) BEVs. At discharge, after adjusting for baseline variables, MG was lower with SEV compared to BEV (8.5 ± 4.7 mmHg vs. 10.6 ± 4.9 mmHg, p < 0.001), however change in KCCQ score was similar for both (31.1 ± 21.8 [SEV] vs. 31.7 ± 22.9 [BEVs], p = 0.68). In the combined cohort, discharge MG was not associated with improvement in 1-month or 1-year KCCQ and did not predict change in 1-month or 1-year NYHA class. Patients with higher NYHA classifications exhibited smaller changes in KCCQ scores from baseline at 30 days. (p < 0.001).

Conclusion

In this study of TAVR patients, echocardiogram-derived MG at discharge was not associated with quality-of-life improvement as determined by change in KCCQ or NYHA class at 1 month or 1 year.

背景:经导管主动脉瓣置换术(TAVR)是严重主动脉瓣狭窄患者迅速扩大的选择。TAVR已被证明可以提高生存率和生活质量。然而,tavr后超声心动图梯度与生活质量之间的关系尚未得到很好的研究或比较自扩(sev)和球囊可扩(bev)瓣膜。目的:探讨tavr术后超声心动图梯度与生活质量的对应关系。方法:在TAVR患者的多中心回顾性登记中,使用堪萨斯城心肌病问卷(KCCQ)检查1个月和1年的经胸超声心动图(TTE)出院平均梯度(MG)与生活质量评分之间的关系。结果:在研究期间,来自两家高容量机构的1093例患者获得了1个月的完整KCCQ数据和出院MG数据。其中包括410辆(37%)纯电动汽车和683辆(63%)纯电动汽车。出院时,在调整基线变量后,与BEV相比,SEV的MG较低(8.5±4.7 mmHg vs. 10.6±4.9 mmHg)。结论:在这项TAVR患者的研究中,出院时超声心动图得出的MG与生活质量改善无关,这是通过1个月或1年的KCCQ或NYHA分级的变化来确定的。
{"title":"Relationship of Hemodynamic Improvement and Quality of Life Outcomes After Transcatheter Aortic Valve Replacement","authors":"Hamza Lodhi,&nbsp;Houman Khalili,&nbsp;Arthur Pavlovsky,&nbsp;Guilherme Attizzani,&nbsp;Sameer Saleem,&nbsp;Sajjad Haider,&nbsp;Mohammad Abdul-Waheed,&nbsp;Muhammad Akbar,&nbsp;Mohammed Kazimuddin,&nbsp;Amr E. Abbas","doi":"10.1002/ccd.70281","DOIUrl":"10.1002/ccd.70281","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Transcatheter aortic valve replacement (TAVR) is a rapidly expanding option for patients with severe aortic stenosis. TAVR has been shown to improve both survival and quality of life. However, the relationship between post-TAVR echocardiographic gradient and quality of life has not been well studied or compared in self-expanding (SEVs) and balloon expandable (BEVs) valves.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>To explore correspondence of post-TAVR echocardiographic gradients and quality of life outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In a multicenter retrospective registry of patients undergoing TAVR the relationship between discharge mean gradient (MG) on transthoracic echocardiography (TTE) and quality-of-life scores using Kansas City Cardiomyopathy Questionnaire (KCCQ) was examined at 1 month and 1 year.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>During the study period, complete data for 1 month KCCQ and discharge MG data was available in 1093 patients from two high volume institutions. These included 410 (37%) SEVs and 683 (63%) BEVs. At discharge, after adjusting for baseline variables, MG was lower with SEV compared to BEV (8.5 ± 4.7 mmHg vs. 10.6 ± 4.9 mmHg, <i>p</i> &lt; 0.001), however change in KCCQ score was similar for both (31.1 ± 21.8 [SEV] vs. 31.7 ± 22.9 [BEVs], <i>p</i> = 0.68). In the combined cohort, discharge MG was not associated with improvement in 1-month or 1-year KCCQ and did not predict change in 1-month or 1-year NYHA class. Patients with higher NYHA classifications exhibited smaller changes in KCCQ scores from baseline at 30 days. (<i>p</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In this study of TAVR patients, echocardiogram-derived MG at discharge was not associated with quality-of-life improvement as determined by change in KCCQ or NYHA class at 1 month or 1 year.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"70-75"},"PeriodicalIF":1.9,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145433670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Impact of Lactate Levels on Admission in STEMI Patients With Cardiogenic Shock Treated With IMPELLA” 对“乳酸水平对STEMI合并IMPELLA治疗心源性休克患者入院的影响”的评论。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-03 DOI: 10.1002/ccd.70295
Mian Zain Hayat, Meer Hassan Khalid, Muhammad Ahmad, Ahmad Furqan Anjum
{"title":"Comment on “Impact of Lactate Levels on Admission in STEMI Patients With Cardiogenic Shock Treated With IMPELLA”","authors":"Mian Zain Hayat,&nbsp;Meer Hassan Khalid,&nbsp;Muhammad Ahmad,&nbsp;Ahmad Furqan Anjum","doi":"10.1002/ccd.70295","DOIUrl":"10.1002/ccd.70295","url":null,"abstract":"","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"86-87"},"PeriodicalIF":1.9,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145433648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Propyl Gallate-Based Paclitaxel-Coated Balloon for the Side Branch Treatment in Coronary Bifurcation Lesions 一种新型的以没食子酸丙酯为基础的紫杉醇包被球囊用于冠状动脉分支病变的侧支治疗。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-03 DOI: 10.1002/ccd.70290
Zhifeng Yao, You Zhou, Jiasheng Yin, Yizhe Wu, Li Shen, Hao Lu, Jianying Ma, Juying Qian, Zheyong Huang, Junbo Ge

Background

Drug-coated balloons are emerging as an important approach for the treatment of coronary bifurcation lesions (CBL).

Aims

This study aimed to evaluate the efficacy and safety of a novel paclitaxel-coated balloon (PCB), which used propyl gallate (PG) as the excipient, in treating the side branch of de novo CBL.

Methods

In this multicenter, randomized, non-inferiority trial, 236 patients across 17 centers were 1:1 randomized to the PG-based PCB or iohexol-based PCB groups. After stent deployment in the main vessel, the side branch was dilated with the allocated PCB. Angiographic follow-up was planned at 9 months and clinical follow-up at 12 months. The primary endpoint was diameter stenosis (DS) in the side branch during the angiographic follow-up.

Results

DS in the side branch was 21.3 ± 23.8% in the PG group versus 21.7 ± 24.3% in the control group (p = 0.198). After adjustment for centers, the difference of DS between the PG group and the control group was −0.11% (95% confidence interval, −6.84% to 6.62%), meeting the prespecified non-inferiority margin of 7%. Clinical outcomes at 12 months were comparable between groups.

Conclusions

The PG-based PCB demonstrated non-inferior efficacy and safety in comparison with the iohexol-based PCB for side branch treatment in de novo CBL. The PG-based PCB could be used as a therapeutic alternative in CBL revascularization.

背景:药物包被球囊正在成为治疗冠状动脉分叉病变(CBL)的一种重要方法。目的:评价以没食子酸丙酯(PG)为辅料的新型紫杉醇包被球囊(PCB)治疗新生CBL侧支的疗效和安全性。方法:在这项多中心、随机、非劣效性试验中,来自17个中心的236名患者以1:1的比例随机分为以pg为基础的PCB组或以碘己醇为基础的PCB组。支架置入主血管后,侧支用分配的PCB进行扩张。9个月时进行血管造影随访,12个月时进行临床随访。在血管造影随访期间,主要终点是侧支直径狭窄(DS)。结果:PG组侧支DS为21.3±23.8%,对照组为21.7±24.3% (p = 0.198)。经中心校正后,PG组与对照组的DS差异为-0.11%(95%置信区间,-6.84% ~ 6.62%),满足预定的7%的非劣效性边际。12个月的临床结果在两组之间具有可比性。结论:与以碘己醇为基础的PCB相比,pg为基础的PCB在治疗新发CBL的侧分支方面具有良好的疗效和安全性。pg基PCB可作为CBL血运重建术的治疗选择。
{"title":"A Novel Propyl Gallate-Based Paclitaxel-Coated Balloon for the Side Branch Treatment in Coronary Bifurcation Lesions","authors":"Zhifeng Yao,&nbsp;You Zhou,&nbsp;Jiasheng Yin,&nbsp;Yizhe Wu,&nbsp;Li Shen,&nbsp;Hao Lu,&nbsp;Jianying Ma,&nbsp;Juying Qian,&nbsp;Zheyong Huang,&nbsp;Junbo Ge","doi":"10.1002/ccd.70290","DOIUrl":"10.1002/ccd.70290","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Drug-coated balloons are emerging as an important approach for the treatment of coronary bifurcation lesions (CBL).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>This study aimed to evaluate the efficacy and safety of a novel paclitaxel-coated balloon (PCB), which used propyl gallate (PG) as the excipient, in treating the side branch of de novo CBL.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this multicenter, randomized, non-inferiority trial, 236 patients across 17 centers were 1:1 randomized to the PG-based PCB or iohexol-based PCB groups. After stent deployment in the main vessel, the side branch was dilated with the allocated PCB. Angiographic follow-up was planned at 9 months and clinical follow-up at 12 months. The primary endpoint was diameter stenosis (DS) in the side branch during the angiographic follow-up.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>DS in the side branch was 21.3 ± 23.8% in the PG group versus 21.7 ± 24.3% in the control group (<i>p</i> = 0.198). After adjustment for centers, the difference of DS between the PG group and the control group was −0.11% (95% confidence interval, −6.84% to 6.62%), meeting the prespecified non-inferiority margin of 7%. Clinical outcomes at 12 months were comparable between groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The PG-based PCB demonstrated non-inferior efficacy and safety in comparison with the iohexol-based PCB for side branch treatment in de novo CBL. The PG-based PCB could be used as a therapeutic alternative in CBL revascularization.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"91-100"},"PeriodicalIF":1.9,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145440509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are We Missing the Forest for the Trees? How Bayesian Meta-Analysis Could Reshape Evidence in Cardiology 我们是否只见树木不见森林?贝叶斯荟萃分析如何重塑心脏病学证据。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-03 DOI: 10.1002/ccd.70298
Vinícius Martins Rodrigues Oliveira, Lucas M. Barbosa
{"title":"Are We Missing the Forest for the Trees? How Bayesian Meta-Analysis Could Reshape Evidence in Cardiology","authors":"Vinícius Martins Rodrigues Oliveira,&nbsp;Lucas M. Barbosa","doi":"10.1002/ccd.70298","DOIUrl":"10.1002/ccd.70298","url":null,"abstract":"","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"88-90"},"PeriodicalIF":1.9,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145440463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angioplasty-Assisted, Suture-Mediated Vascular Closure Enabling Percutaneous Transfemoral TAVR in Case of a Diseased Puncture Site. The FEM-PREP Technique 血管成形术辅助,缝合线介导的血管闭合在病变穿刺部位实现经皮经股TAVR。FEM-PREP技术。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-02 DOI: 10.1002/ccd.70285
Agostino Spano', Ole De Backer, Ignacio J. Amat-Santos, Marouane Boukhris, Adrien Jossart, Jacques Auslender, Giuseppe Colletti, Mihai Cocoi, Claudiu Ungureanu

Background

Suture-mediated closure using the ProGlide system can fail during transfemoral transcatheter aortic valve implantation (TAVR) in patients with heavily calcified femoral arteries, complicating vascular access management.

Methods

We describe a case series of three TAVR procedure in which ProGlide pre-closure failed due to calcified plaques impairing footplate apposition, despite accurate ultrasound-guided puncture. Then, a bailout strategy involving femoral angioplasty via a secondary vascular access, the Fem-PREP (Femoral Preparation for Preclosure) technique, was employed to improve vessel compliance and luminal diameter.

Results

The Fem-PREP technique provided minimal space required for adequate ProGlide footplate mobility, reducing plaque interference and enabling successful suture deployment in all cases without vascular complications.

Conclusions

Targeted femoral angioplasty using Fem-PREP may overcome one of the key mechanical limitation associated with pre-closure failure in calcified femoral arteries, offering a simple and effective adjunctive technique in selected TAVR patients.

背景:对于严重钙化的股动脉患者,在经股导管主动脉瓣植入术(TAVR)中,使用ProGlide系统进行缝合关闭可能会失败,使血管通路管理复杂化。方法:我们描述了三例TAVR手术的病例系列,尽管超声引导下准确穿刺,但由于钙化斑块损害了足跖位置,ProGlide预闭合失败。然后,通过次级血管通道进行股骨血管成形术,Fem-PREP(股骨预封闭准备)技术,以改善血管顺应性和管腔直径。结果:Fem-PREP技术提供了足够的ProGlide足板活动所需的最小空间,减少了斑块干扰,并在所有病例中成功展开缝线,无血管并发症。结论:femm - prep靶向股动脉成形术可以克服与钙化股动脉预闭合失败相关的关键力学限制之一,为部分TAVR患者提供了一种简单有效的辅助技术。
{"title":"Angioplasty-Assisted, Suture-Mediated Vascular Closure Enabling Percutaneous Transfemoral TAVR in Case of a Diseased Puncture Site. The FEM-PREP Technique","authors":"Agostino Spano',&nbsp;Ole De Backer,&nbsp;Ignacio J. Amat-Santos,&nbsp;Marouane Boukhris,&nbsp;Adrien Jossart,&nbsp;Jacques Auslender,&nbsp;Giuseppe Colletti,&nbsp;Mihai Cocoi,&nbsp;Claudiu Ungureanu","doi":"10.1002/ccd.70285","DOIUrl":"10.1002/ccd.70285","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Suture-mediated closure using the ProGlide system can fail during transfemoral transcatheter aortic valve implantation (TAVR) in patients with heavily calcified femoral arteries, complicating vascular access management.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We describe a case series of three TAVR procedure in which ProGlide pre-closure failed due to calcified plaques impairing footplate apposition, despite accurate ultrasound-guided puncture. Then, a bailout strategy involving femoral angioplasty via a secondary vascular access, the Fem-PREP (Femoral Preparation for Preclosure) technique, was employed to improve vessel compliance and luminal diameter.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The Fem-PREP technique provided minimal space required for adequate ProGlide footplate mobility, reducing plaque interference and enabling successful suture deployment in all cases without vascular complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Targeted femoral angioplasty using Fem-PREP may overcome one of the key mechanical limitation associated with pre-closure failure in calcified femoral arteries, offering a simple and effective adjunctive technique in selected TAVR patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"61-69"},"PeriodicalIF":1.9,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145433636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidewire Manipulation Based on Establishment of Stereo Perception in Percutaneous Coronary Intervention 经皮冠状动脉介入治疗中基于立体感知建立的导丝手法。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-02 DOI: 10.1002/ccd.70287
Miao Chen, Huiqiang Zhao, Xiantao Song

Background

Traditional percutaneous coronary intervention (PCI) relies on two-dimensional X-ray imaging, but this does not allow depth perception and complicates precise manipulation of the guidewire. Our purpose was to develop a novel method for guidewire manipulation by establishing stereoscopic perception in coronary angiography (CAG), as described in our previous study, and thereby improve the precision and success rate of PCI.

Methods

Based on establishment of stereo perception in CAG, we used digital subtraction angiography (DSA) with gantry rotation and simulation with UG NX software to determine the orientation of the guidewire tip and the relative positions of the true lumen and false lumen. We then performed verification using a highly realistic 3D-printed transparent silicone model of the human heart and coronary arteries. By manipulating the guidewire in various branches of the model of the coronary artery, we identified the directional torque of wire rotation and simulated this using UG NX software. A preliminary trial with unidirectional rotation was conducted in which one interventionist performed 60 guidewire manipulations (30 before and 30 after training) in a 3D-printed heart model to quantify changes in directional accuracy.

Results

The results confirmed that the orientation of the distal tip of the guidewire and the relative positions of the true and false lumens were accurately determined using DSA with gantry rotation and simulation with UG NX software. We also validated the consistency of rotational torque within the coronary artery lumen, irrespective of vessel twisting and deformation. The preliminary trial demonstrated a higher success rate (93.3% vs. 60%, p < 0.01) after training.

Conclusion

Our novel method significantly improved the accuracy of guidewire manipulation in an in vitro model. This method therefore has the potential to enhance PCI outcome, and warrants further examination by clinical trials.

背景:传统的经皮冠状动脉介入治疗(PCI)依赖于二维x线成像,但这不能实现深度感知,并且使导丝的精确操作复杂化。我们的目的是开发一种新的方法,通过在冠状动脉造影(CAG)中建立立体感知来操纵导丝,从而提高PCI的准确性和成功率。方法:在CAG立体感知建立的基础上,采用龙门旋转数字减影血管造影(DSA), UG NX软件进行模拟,确定导丝尖端的方位以及真腔和假腔的相对位置。然后,我们使用高度逼真的3d打印透明硅胶人体心脏和冠状动脉模型进行验证。通过对冠状动脉模型各分支导丝的操作,确定导丝旋转的定向扭矩,并利用UG NX软件进行仿真。进行了一项单向旋转的初步试验,其中一名介入医生在3d打印的心脏模型中进行了60次导丝操作(训练前30次,训练后30次),以量化方向精度的变化。结果:采用龙门旋转DSA及UG NX软件进行仿真,证实了导丝远端方向及真假腔相对位置的准确确定。我们还验证了冠状动脉管腔内旋转扭矩的一致性,无论血管扭曲和变形如何。初步试验显示了更高的成功率(93.3% vs. 60%) p结论:我们的新方法显著提高了体外模型导丝操作的准确性。因此,该方法具有提高PCI疗效的潜力,值得临床试验进一步检验。
{"title":"Guidewire Manipulation Based on Establishment of Stereo Perception in Percutaneous Coronary Intervention","authors":"Miao Chen,&nbsp;Huiqiang Zhao,&nbsp;Xiantao Song","doi":"10.1002/ccd.70287","DOIUrl":"10.1002/ccd.70287","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Traditional percutaneous coronary intervention (PCI) relies on two-dimensional X-ray imaging, but this does not allow depth perception and complicates precise manipulation of the guidewire. Our purpose was to develop a novel method for guidewire manipulation by establishing stereoscopic perception in coronary angiography (CAG), as described in our previous study, and thereby improve the precision and success rate of PCI.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Based on establishment of stereo perception in CAG, we used digital subtraction angiography (DSA) with gantry rotation and simulation with UG NX software to determine the orientation of the guidewire tip and the relative positions of the true lumen and false lumen. We then performed verification using a highly realistic 3D-printed transparent silicone model of the human heart and coronary arteries. By manipulating the guidewire in various branches of the model of the coronary artery, we identified the directional torque of wire rotation and simulated this using UG NX software. A preliminary trial with unidirectional rotation was conducted in which one interventionist performed 60 guidewire manipulations (30 before and 30 after training) in a 3D-printed heart model to quantify changes in directional accuracy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The results confirmed that the orientation of the distal tip of the guidewire and the relative positions of the true and false lumens were accurately determined using DSA with gantry rotation and simulation with UG NX software. We also validated the consistency of rotational torque within the coronary artery lumen, irrespective of vessel twisting and deformation. The preliminary trial demonstrated a higher success rate (93.3% vs. 60%, <i>p</i> &lt; 0.01) after training.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our novel method significantly improved the accuracy of guidewire manipulation in an in vitro model. This method therefore has the potential to enhance PCI outcome, and warrants further examination by clinical trials.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"76-85"},"PeriodicalIF":1.9,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccd.70287","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145433677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Durability of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Systematic Review and Meta-Analysis 球囊扩张与自扩张经导管主动脉瓣的长期耐用性:一项系统综述和荟萃分析。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-30 DOI: 10.1002/ccd.70294
Saverio Continisio, Andrea R. Munafò, Carolina Montonati, Riccardo Terzi, Emiliano Boldi, Alfonso Ielasi, Claudio Montalto, Francesco Soriano, Jacopo A. Oreglia, Federico De Marco, Antonio Silvestro, Tommaso Fabris, Edwin Ho, Francesco Saia, Giuseppe Tarantini, Cosmo Godino, Francesco Maisano, Gilbert H. L. Tang, Azeem Latib, Andrea Scotti

Background

Transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS) is increasingly performed in younger patients with long life expectancy. However, limited data exist on the durability of transcatheter heart valves (THVs).

Aims

The aim of the present work is to compare the long-term durability of balloon-expandable (BEV) and self-expanding (SEV) THVs after TAVR.

Methods

Electronic databases were searched up to May 2025 for studies reporting on the long-term durability of THVs in patients undergoing TAVR with a minimum follow-up of 5 years. Pooled odds ratios (ORs) with 95% confidence interval (CI) were used as summary statistics and were calculated using a random-effects model. Co-primary endpoints were moderate and severe structural valve deterioration (SVD) and the occurrence of all-cause bioprosthetic valve failure (BVF). All-cause death was the secondary endpoint.

Results

A total of 22 studies and 12,131 patients undergoing TAVR were included: 52.5% of patients (n = 6362) received BEV, 47.5% (n = 5769) SEV. An old-generation THV was used in 84.5% of cases. At a median follow-up of 7 (5−8.3) years, the overall pooled estimates of moderate/severe SVD and BVF were 7% (5−9) and 4% (3−5), respectively. Patients treated with a BEV experienced a higher rate of SVD (OR: 2.09; 95% CI: 1.58−2.75; p < 0.001) and BVF (OR: 1.61; 95% CI: 1.10−2.36; p = 0.014); no difference was observed in terms of all-cause death.

Conclusions

At long-term follow-up after TAVR, patients receiving a BEV experienced higher rates of moderate/severe SVD and of BVF compared to those having a SEV. However, no significant differences between the two THV designs were observed on the clinical endpoint of all-cause death.

背景:经导管主动脉瓣置换术(TAVR)治疗主动脉瓣狭窄(AS)越来越多地用于预期寿命长的年轻患者。然而,关于经导管心脏瓣膜(thv)耐久性的数据有限。目的:本研究的目的是比较气球膨胀式(BEV)和自膨胀式(SEV) thv在TAVR后的长期耐久性。方法:电子数据库检索截至2025年5月的关于TAVR患者thv长期持久性的研究报告,至少随访5年。采用95%置信区间(CI)的合并优势比(ORs)作为汇总统计,并采用随机效应模型计算。共同主要终点是中度和重度结构性瓣膜恶化(SVD)和全因生物假体瓣膜衰竭(BVF)的发生。全因死亡是次要终点。结果:共纳入22项研究,12131例接受TAVR的患者:52.5% (n = 6362)的患者接受BEV, 47.5% (n = 5769)的患者接受SEV。84.5%的病例使用老一代THV。在中位随访7年(5-8.3年)时,中度/重度SVD和BVF的总体汇总估计值分别为7%(5-9年)和4%(3-5年)。接受BEV治疗的患者SVD发生率更高(OR: 2.09; 95% CI: 1.58-2.75; p)结论:在TAVR后的长期随访中,与接受SEV治疗的患者相比,接受BEV治疗的患者出现中度/重度SVD和BVF的发生率更高。然而,两种THV设计在全因死亡的临床终点上没有观察到显著差异。
{"title":"Long-Term Durability of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Systematic Review and Meta-Analysis","authors":"Saverio Continisio,&nbsp;Andrea R. Munafò,&nbsp;Carolina Montonati,&nbsp;Riccardo Terzi,&nbsp;Emiliano Boldi,&nbsp;Alfonso Ielasi,&nbsp;Claudio Montalto,&nbsp;Francesco Soriano,&nbsp;Jacopo A. Oreglia,&nbsp;Federico De Marco,&nbsp;Antonio Silvestro,&nbsp;Tommaso Fabris,&nbsp;Edwin Ho,&nbsp;Francesco Saia,&nbsp;Giuseppe Tarantini,&nbsp;Cosmo Godino,&nbsp;Francesco Maisano,&nbsp;Gilbert H. L. Tang,&nbsp;Azeem Latib,&nbsp;Andrea Scotti","doi":"10.1002/ccd.70294","DOIUrl":"10.1002/ccd.70294","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS) is increasingly performed in younger patients with long life expectancy. However, limited data exist on the durability of transcatheter heart valves (THVs).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>The aim of the present work is to compare the long-term durability of balloon-expandable (BEV) and self-expanding (SEV) THVs after TAVR.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Electronic databases were searched up to May 2025 for studies reporting on the long-term durability of THVs in patients undergoing TAVR with a minimum follow-up of 5 years. Pooled odds ratios (ORs) with 95% confidence interval (CI) were used as summary statistics and were calculated using a random-effects model. Co-primary endpoints were moderate and severe structural valve deterioration (SVD) and the occurrence of all-cause bioprosthetic valve failure (BVF). All-cause death was the secondary endpoint.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 22 studies and 12,131 patients undergoing TAVR were included: 52.5% of patients (<i>n</i> = 6362) received BEV, 47.5% (<i>n</i> = 5769) SEV. An old-generation THV was used in 84.5% of cases. At a median follow-up of 7 (5−8.3) years, the overall pooled estimates of moderate/severe SVD and BVF were 7% (5−9) and 4% (3−5), respectively. Patients treated with a BEV experienced a higher rate of SVD (OR: 2.09; 95% CI: 1.58−2.75; <i>p</i> &lt; 0.001) and BVF (OR: 1.61; 95% CI: 1.10−2.36; <i>p</i> = 0.014); no difference was observed in terms of all-cause death.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>At long-term follow-up after TAVR, patients receiving a BEV experienced higher rates of moderate/severe SVD and of BVF compared to those having a SEV. However, no significant differences between the two THV designs were observed on the clinical endpoint of all-cause death.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"48-60"},"PeriodicalIF":1.9,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145411373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intentional Stent Fracture to Accommodate Growth After Coarctation Stenting in an 860-g Neonate 一名860克新生儿缩窄支架植入术后有意支架断裂以适应生长。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-29 DOI: 10.1002/ccd.70291
Magdalena Cuman, Gernot Buheitel, Peter Ewert, Stanimir Georgiev

Background

Congenital aortic coarctation in neonates and children can be managed with transcatheter stent implantation, but this approach raises the issue of how to accommodate the fixed stent structure within the growing vessel.

Case Summary

A 15-month-old boy, born prematurely with critical aortic coarctation, was treated at 1 week of age with the implantation of a coronary stent. Subsequently, multiple stent dilatations were needed to adapt it to the growing aortic vessel. At 3 months the patient underwent balloon dilation with the simultaneous implantation of a second stent, and after 1 year an ultra-high-pressure balloon dilatation with intentional fracture of the coronary stent was performed.

Discussion

To overcome the problem of stenting a growing vessel, intentional stent fracture (ISF) with ultrahigh-pressure (UHP) balloon has been introduced and applied in a limited number of patients. In piglet models, the ISF technique was associated with a significant incidence of complications, which were preventable (with the exception of stent fragment embolization) by performing pre-stenting before ISF.

背景:新生儿和儿童的先天性主动脉缩窄可以通过经导管支架植入术来治疗,但这种方法提出了如何在生长血管内容纳固定支架结构的问题。病例总结:一名15个月大的男婴,早产时伴有严重主动脉缩窄,在1周龄时接受冠状动脉支架植入治疗。随后,需要进行多次支架扩张以适应不断生长的主动脉血管。3个月时,患者行球囊扩张术,同时植入第二个支架。1年后,患者行超高压球囊扩张术,并故意破坏冠状动脉支架。讨论:为了克服血管生长的问题,超高压球囊故意支架骨折(ISF)已被引入并应用于有限数量的患者。在仔猪模型中,ISF技术与并发症的显著发生率相关,这些并发症可以通过在ISF之前进行预支架置入来预防(支架碎片栓塞除外)。
{"title":"Intentional Stent Fracture to Accommodate Growth After Coarctation Stenting in an 860-g Neonate","authors":"Magdalena Cuman,&nbsp;Gernot Buheitel,&nbsp;Peter Ewert,&nbsp;Stanimir Georgiev","doi":"10.1002/ccd.70291","DOIUrl":"10.1002/ccd.70291","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Congenital aortic coarctation in neonates and children can be managed with transcatheter stent implantation, but this approach raises the issue of how to accommodate the fixed stent structure within the growing vessel.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Summary</h3>\u0000 \u0000 <p>A 15-month-old boy, born prematurely with critical aortic coarctation, was treated at 1 week of age with the implantation of a coronary stent. Subsequently, multiple stent dilatations were needed to adapt it to the growing aortic vessel. At 3 months the patient underwent balloon dilation with the simultaneous implantation of a second stent, and after 1 year an ultra-high-pressure balloon dilatation with intentional fracture of the coronary stent was performed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>To overcome the problem of stenting a growing vessel, intentional stent fracture (ISF) with ultrahigh-pressure (UHP) balloon has been introduced and applied in a limited number of patients. In piglet models, the ISF technique was associated with a significant incidence of complications, which were preventable (with the exception of stent fragment embolization) by performing pre-stenting before ISF.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"34-37"},"PeriodicalIF":1.9,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccd.70291","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145403719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: “Expanding the Scope of Pigtail-Assisted Transradial Access: The Need for Comparative and Multicenter Evidence” 致编辑的信:“扩大辫状辅助跨放射状通路的范围:需要比较和多中心证据”。
IF 1.9 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-29 DOI: 10.1002/ccd.70293
Muhammad Ahmad, Meer Hassan Khalid, Ahmad Furqan Anjum
{"title":"Letter to the Editor: “Expanding the Scope of Pigtail-Assisted Transradial Access: The Need for Comparative and Multicenter Evidence”","authors":"Muhammad Ahmad,&nbsp;Meer Hassan Khalid,&nbsp;Ahmad Furqan Anjum","doi":"10.1002/ccd.70293","DOIUrl":"10.1002/ccd.70293","url":null,"abstract":"","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"107 1","pages":"40-41"},"PeriodicalIF":1.9,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145403715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Catheterization and Cardiovascular Interventions
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1